HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,213-1,224 of 7,264
Drug study icon
UnknownNCT05809609

Glutamate Emotion Memory Study

Official study title

Does Modulation of Glutamate Transmission in the Brain Using a Sub-anaesthetic Dose of Ketamine Affect Autobiographical Memory, Emotional Processing and Decision-making in Treatment-resistant Depression?

Current recruitment status is unconfirmed.

In Oxford
DepressionMedication studyAges 20–60
Countries
United Kingdom
Sponsor
University of Oxford (University)
Drug study icon
Active Not RecruitingNCT06480500

I-CBT and IV Ketamine for Suicide prevention for treatment-resistant depression

Official study title

Integrated Internet-Based Cognitive Behavioural Therapy (i-CBT) and Intravenous Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial

This study is no longer accepting new participants.

In Toronto
Depression, SuicidalityMedication studyAges 21–65
Countries
Canada
Sponsor
University Health Network, Toronto
Device study icon
CompletedNCT06165445

Optimizing tDCS Protocol for Clinical Use in Major Depressive Disorder

Official study title

Optimized Multichannel tDCS Protocol vs Conventional and Sham tDCS for Clinical Use in Patients With Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Zanjan
DepressionDevice studyAges 18–60
Countries
Iran
Sponsor
The National Brain Mapping Laboratory (NBML)
Device study icon
UnknownNCT06350396

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

Official study title

rTMS Intervention for DMPFC Treatment of Treatment-Resistant Depression Under the Guidance of Personalized Brain Functional Area Dissection (pBFS) Technology

Current recruitment status is unconfirmed.

Multiple locations, including Hebei
DepressionDevice studyAges 18–65
Countries
China
Sponsor
Changping Laboratory
Drug study icon
CompletedNCT06230757

Psilocybin for Treatment-Resistant Depression

Official study title

Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial

This study has finished and is no longer accepting participants.

In Aurora
DepressionMedication studyAges 21–75
Countries
United States
Sponsor
University of Colorado, Denver
Drug study icon
Active Not RecruitingNCT06341426

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Official study title

Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)

This study is no longer accepting new participants.

In Toronto
DepressionMedication studyAges 18–65
Countries
Canada
Sponsor
University Health Network, Toronto
Other study type icon
RecruitingACTRN12609000793213

The Prevention of Depressive Symptoms in Children in a Rural Setting

Official study title

The effect of a mental health promotion program, called Positive Thinking Skills, on depressive and anxiety symptomatology, attribution style, and social and emotional functioning in children aged 8 to 9 years of age in a rural setting.

Location not clearly listed
Depression, AnxietyInterventional studyAges 8–9
Countries
Sponsor
Curtin University of Technology

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.